Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive ImpairmentCherie Strikwerda‐Brown, Jens C. Pruessner, Diana A. Hobbs et al.|JAMA Neurology|2022Cited by 133
Plasma p‐tau231, p‐tau181, <scp>PET</scp> Biomarkers, and Cognitive Change in Older AdultsPierre‐François Meyer, Sylvia Villeneuve, Nicholas J. Ashton et al.|Annals of Neurology|2022Cited by 99
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Oskar Hansson, Nesrine Rahmouni et al.|Nature Aging|2025Cited by 68
Assessment of white matter hyperintensity severity using multimodal magnetic resonance imagingOlivier Parent, Lisa-Marie MÃ ⁄ nter, Aurélie Bussy et al.|Brain Communications|2023Cited by 23
Assessment of white matter hyperintensity severity using multimodal MRI in Alzheimer’s DiseaseOlivier Parent, M. Mallar Chakravarty, Aurélie Bussy et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 5